Search
-
News
New MSK research illuminates new details about Thetis cells that will support efforts to harness them therapeutically; shows how the timing and strength of danger signals steer immune cell fates; and employs single-nucleus DNA sequencing to shed new light on the evolution of pancreatic cancer.
… Wednesday, February 4, 2026 New research from Memorial Sloan Kettering Cancer Center (MSK) illuminates new details about Thetis cells that will support efforts to harness them therapeutically; shows how the timing and strength of danger signals steer immune cell fates; and employs single-nucleus DNA
-
News
Everolimus plus bevacizumab demonstrates robust activity in treatment-naïve patients with advanced papillary variant nonclear cell renal cell carcinoma.
… Monday, November 9, 2020 Everolimus plus bevacizumab demonstrates robust activity in treatment-naïve patients with advanced papillary variant nonclear cell renal cell carcinoma (nccRCC), according to the results of an expanded single-arm, single-institution phase II trial conducted at Memorial Sloan
-
News
Learn how to get enough calories during treatment from MSK specialists in diet and nutrition.
… Tuesday, January 15, 2019 Summary MSK experts offer tips on how people who are currently in cancer treatment can get enough vital calories when they need them most. During cancer treatment, many people face a nutritional double whammy. The disease can rob them of their appetite and sap their strength
-
News
BCG has been used to treat bladder cancer for more than 30 years. Scientists are still learning how it works.
… Friday, July 17, 2020 Summary Scientists at Memorial Sloan Kettering have found that BCG, a commonly used immunotherapy for bladder cancer , works differently than many researchers had assumed. For people with early-stage bladder cancer, an immunotherapy called BCG has been the standard treatment for
-
News
… Friday, September 30, 2022 The idea came to Swathi Iyer on the subway, while headed to a Broadway show: The best way to explain brain cancer’s need for cholesterol is to liken it to an addiction. And the processes that regulate cholesterol activity present in normal brain cells are like the local police
-
News
Pharmacist and herbalist Simon Yeung gives consumers tips on how to determine whether an herb or dietary supplement contains what’s indicated on the label.
… Friday, January 17, 2014 Summary Pharmacist and herbalist Simon Yeung gives consumers tips on how to determine whether an herb or dietary supplement contains what’s indicated on the label. Many people search the web, ask friends and family, or look in reference books when they want to know if an herb
-
News
Two brothers discuss their surprise at being diagnosed with Lynch syndrome.
… Thursday, July 19, 2018 Summary One man’s cancer diagnosis spurs his brother to undergo more frequent cancer screenings, a decision that may have saved his life. When his younger brother, Mitchell, was found to have urothelial cancer in 2011, Elliot Katz never expected that diagnosis might save his own
-
News
Luis A. Diaz, MD, has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz most recently served as an associate professor of oncology at the Johns Hopkins University School of Medicine. Dr. Diaz formally assumes the role as David Spriggs, MD, steps down after nearly 13 years.
… Monday, April 17, 2017 Luis A. Diaz, MD , has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz most recently served as an
-
News
In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information. A new longitudinal study from researchers at Memorial Sloan Kettering Cancer Center finds that while clinicians' and patients' reporting of treatment side effects are very different from each other, together they provide a more complete, clinically meaningful picture of the treatment experience.
… Monday, November 16, 2009 In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information. A new
-
MSK News
For many people with lung cancer, targeted therapies can provide effective, long-term control of their disease with fewer side effects than chemotherapy.
… Wednesday, January 1, 2020 Middle school chorus and orchestra teacher Melissa Crouse had lived in the Pittsburgh area her whole life. But on a trip to visit her brother in southwest Florida, she decided on a whim to apply for teaching jobs there. The single mom, then 51, quickly received an offer. “Three